As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Generic Injectables Market: By Application: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular; By Container: Vials, Ampoules, Premix; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2015-2025); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Generic Injectables Market Outlook

The global generic injectables market size was nearly USD 32 billion in 2019. The market is further expected to grow at a CAGR of 9% in the forecast period of 2020-2025 to attain USD 54 billion by 2025.

The global generic injectables market is being driven by the growing prevalence of cancer, cardiovascular, and other diseases across the globe, coupled with rising demand for such drugs to assist patients undergoing chemotherapy, alleviating after-effects, including pain. The oncology segment, among other applications, dominates the industry, occupying a significant share. Among various distribution channels, hospitals account for the largest market share.

Region-wise, North America is the leading market, accounting for over a half of the total share. The growth of the global generic injectables market in the region can be attributed to the availability of advanced technology and enhanced healthcare infrastructure. On the other hand, the Asia Pacific is expected to be one of the emerging markets owing to the increased government expenditure in the healthcare sector in the region coupled with the presence of large population.

 

Properties and Applications

Generic injectables refer to the injectables that are bioequivalent of their branded counterparts and are not protected by drug patents. They are similar to original drugs and are safe and effective. They comprise of similar active ingredients, dosage, quality, and strength as their original counterparts, and, thus, their performance, intended use, quality, form, and route of administration are similar to that of their original counterparts.

Based on applications, the industry is divided into:

  • Oncology
  • Anaesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular
  • Others

On the basis of containers, the industry is categorised into:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
  • Others

On the basis of distribution channel, the industry can be further segmented into:

  • Hospitals
  • Retail Pharmacy 

The report further analyses the regional markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Market Analysis

The global generic injectables market is driven by the growing prevalence of chronic, lethal, as well as lifestyle diseases across the globe, coupled with high costs associated with their treatment. These drugs are bioequivalent of and are used as an alternative means to brand-name medicines, providing similar pharmacological effects in the treatment of various diseases. With the rise in the number of patients, the use of generic injectables is growing as they save time and provide a quick relief by getting injected directly into the bloodstream.

Although the production of generic injectables is complex, their research and development investment is cheaper and takes less time. Unlike branded drug manufacturers, generic drug manufacturers need not invest heavily in the manufacturing and marketing of their products. The sudden increase in the overall healthcare costs has boosted the demand for these injectables. Further, the growing preference of generic oncology drugs for treating cancer patients is also contributing to the global generic injectables market. Rising geriatric population and growing demand for cost-effective treatment procedures, particularly in emerging regions are aiding the industry further.

Additionally, an increase in the shortage of drugs, especially in the United States, along with patent expiry of a number of useful and famous drugs, is, in turn, boosting the global generic injectables market. The growing research and development activities are aiding the market growth. Moreover, to satisfy the growing consumer demand, the leading players in the market are innovating and launching enhanced products. The development of the latest formulations by manufacturers is expected to have a positive effect on the global generic injectables market over the forecast period.  

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the global generic injectables market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Fresenius Kabi 
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Sanofi
  • Sandoz (Novartis)
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Generic Drugs Market Overview

    8.1    Key Industry Highlights
    8.2    Global Generic Drugs Historical Market (2015-2019) 
    8.3    Global Generic Drugs Market Forecast (2020-2025)
    8.4    Global Generic Drugs Market by Region
        8.4.1    Market Share
            8.4.1.1    North America
            8.4.1.2    Europe
            8.4.1.3    Asia Pacific
            8.4.1.4    Latin America
            8.4.1.5    Middle East and Africa
9    Global Generic Injectables Market Analysis
    9.1    Key Industry Highlights
    9.2    Global Generic Injectables Historical Market (2015-2019) 
    9.3    Global Generic Injectables Market Forecast (2020-2025)
    9.4    Global Generic Injectables Market by Application
        9.4.1    Oncology
            9.4.1.1    Market Share
            9.4.1.2    Historical Trend (2015-2019)
            9.4.1.3    Forecast Trend (2020-2025)
        9.4.2    Anaesthesia
            9.4.2.1    Market Share
            9.4.2.2    Historical Trend (2015-2019)
            9.4.2.3    Forecast Trend (2020-2025)
        9.4.3    Anti-Infectives
            9.4.3.1    Market Share
            9.4.3.2    Historical Trend (2015-2019)
            9.4.3.3    Forecast Trend (2020-2025)
        9.4.4    Parenteral Nutrition
            9.4.4.1    Market Share
            9.4.4.2    Historical Trend (2015-2019)
            9.4.4.3    Forecast Trend (2020-2025)
        9.4.5    Cardiovascular
            9.4.5.1    Market Share
            9.4.5.2    Historical Trend (2015-2019)
            9.4.5.3    Forecast Trend (2020-2025)
        9.4.6    Others
    9.5    Global Generic Injectables Market by Container
        9.5.1    Vials
            9.5.1.1    Market Share
            9.5.1.2    Historical Trend (2015-2019)
            9.5.1.3    Forecast Trend (2020-2025)
        9.5.2    Ampoules
            9.5.2.1    Market Share
            9.5.2.2    Historical Trend (2015-2019)
            9.5.2.3    Forecast Trend (2020-2025)
        9.5.3    Premix
            9.5.3.1    Market Share
            9.5.3.2    Historical Trend (2015-2019)
            9.5.3.3    Forecast Trend (2020-2025)
        9.5.4    Prefilled Syringes
            9.5.4.1    Market Share
            9.5.4.2    Historical Trend (2015-2019)
            9.5.4.3    Forecast Trend (2020-2025)
        9.5.5    Others
    9.6    Global Generic Injectables Market by Distribution Channel
        9.6.1    Hospitals
            9.6.1.1    Market Share
            9.6.1.2    Historical Trend (2015-2019)
            9.6.1.3    Forecast Trend (2020-2025)
        9.6.2    Retail Pharmacy
            9.6.2.1    Market Share
            9.6.2.2    Historical Trend (2015-2019)
            9.6.2.3    Forecast Trend (2020-2025)
    9.7    Global Generic Injectables Market by Region
        9.7.1    Market Share
            9.7.1.1    North America
            9.7.1.2    Europe
            9.7.1.3    Asia Pacific
            9.7.1.4    Latin America
            9.7.1.5    Middle East and Africa
10    Regional Analysis
    10.1    North America
        10.1.1    Historical Trend (2015-2019)
        10.1.2    Forecast Trend (2020-2025)
        10.1.3    Breakup by Country
            10.1.3.1    United States of America 
            10.1.3.2    Canada
    10.2    Europe
        10.2.1    Historical Trend (2015-2019)
        10.2.2    Forecast Trend (2020-2025)
        10.2.3    Breakup by Country
            10.2.3.1    United Kingdom
            10.2.3.2    Germany
            10.2.3.3    France
            10.2.3.4    Italy
            10.2.3.5    Others
    10.3    Asia Pacific
        10.3.1    Historical Trend (2015-2019)
        10.3.2    Forecast Trend (2020-2025)
        10.3.3    Breakup by Country
            10.3.3.1    China
            10.3.3.2    Japan
            10.3.3.3    India
            10.3.3.4    ASEAN
            10.3.3.5    Australia
            10.3.3.6    Others
    10.4    Latin America
        10.4.1    Historical Trend (2015-2019)
        10.4.2    Forecast Trend (2020-2025)
        10.4.3    Breakup by Country
            10.4.3.1    Brazil
            10.4.3.2    Argentina
            10.4.3.3    Mexico
            10.4.3.4    Others
    10.5    Middle East and Africa
        10.5.1    Historical Trend (2015-2019)
        10.5.2    Forecast Trend (2020-2025)
        10.5.3    Breakup by Country
            10.5.3.1    Saudi Arabia
            10.5.3.2    United Arab Emirates
            10.5.3.3    Nigeria
            10.5.3.4    South Africa
            10.5.3.5    Others
11    Market Dynamics
    11.1    SWOT Analysis
        11.1.1    Strengths
        11.1.2    Weaknesses
        11.1.3    Opportunities
        11.1.4    Threats
    11.2    Porter’s Five Forces Analysis
        11.2.1    Supplier’s Power
        11.2.2    Buyer’s Power
        11.2.3    Threat of New Entrants
        11.2.4    Degree of Rivalry
        11.2.5    Threat of Substitutes
    11.3    EMR’s Key Indicators for Demand
    11.4    EMR’s Key Indicators for Price
12    Value Chain Analysis
13    Manufacturing Process

    13.1    Overview
    13.2    Detailed Process Flow
    13.3    Operations Involved
14    Cost Analysis
    14.1    Land, Location, and Site Development
    14.2    Construction
    14.3    Plant Machinery
    14.4    Cost of Raw Material
    14.5    Packaging
    14.6    Transportation
    14.7    Utilities
    14.8    Manpower
    14.9    Other Capital Investment
15    Project Economics
    15.1    Capital Cost of the Project
    15.2    Techno-Economic Parameters
    15.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    15.4    Taxation and Depreciation
    15.5    Income Projections
    15.6    Expenditure Projections
    15.7    Financial Analysis
    15.8    Profit Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Company Profiles
        16.3.1    Fresenius Kabi 
            16.3.1.1    Company Overview
            16.3.1.2    Product Portfolio
            16.3.1.3    Demographic Reach and Achievements
            16.3.1.4    Certifications
        16.3.2    Hikma Pharmaceuticals PLC
            16.3.2.1    Company Overview
            16.3.2.2    Product Portfolio
            16.3.2.3    Demographic Reach and Achievements
            16.3.2.4    Certifications
        16.3.3    Sagent Pharmaceuticals, Inc.
            16.3.3.1    Company Overview
            16.3.3.2    Product Portfolio
            16.3.3.3    Demographic Reach and Achievements
            16.3.3.4    Certifications
        16.3.4    Sanofi
            16.3.4.1    Company Overview
            16.3.4.2    Product Portfolio
            16.3.4.3    Demographic Reach and Achievements
            16.3.4.4    Certifications
        16.3.5    Sandoz (Novartis)
            16.3.5.1    Company Overview
            16.3.5.2    Product Portfolio
            16.3.5.3    Demographic Reach and Achievements
            16.3.5.4    Certifications
        16.3.6    Others
17    Industry Events and Developments


List of Figures and Tables

1.    Global Generic Drugs Market: Key Industry Highlights, 2015 and 2025
2.    Global Generic Drugs Historical Market: Breakup by Region (USD Billion), 2015-2019
3.    Global Generic Drugs Market Forecast: Breakup by Region (USD Billion), 2020-2025
4.    Global Generic Injectables Market: Key Industry Highlights, 2015 and 2025
5.    Global Generic Injectables Historical Market: Breakup by Application (USD Billion), 2015-2019
6.    Global Generic Injectables Market Forecast: Breakup by Application (USD Billion), 2020-2025
7.    Global Generic Injectables Historical Market: Breakup by Container (USD Billion), 2015-2019
8.    Global Generic Injectables Market Forecast: Breakup by Container (USD Billion), 2020-2025
9.    Global Generic Injectables Historical Market: Breakup by Distribution Channel (USD Billion), 2015-2019
10.    Global Generic Injectables Market Forecast: Breakup by Distribution Channel (USD Billion), 2020-2025
11.    Global Generic Injectables Historical Market: Breakup by Region (USD Billion), 2015-2019
12.    Global Generic Injectables Market Forecast: Breakup by Region (USD Billion), 2020-2025
13.    North America Generic Injectables Historical Market: Breakup by Country (USD Billion), 2015-2019
14.    North America Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2020-2025
15.    Europe Generic Injectables Historical Market: Breakup by Country (USD Billion), 2015-2019
16.    Europe Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2020-2025
17.    Asia Pacific Generic Injectables Historical Market: Breakup by Country (USD Billion), 2015-2019
18.    Asia Pacific Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2020-2025
19.    Latin America Generic Injectables Historical Market: Breakup by Country (USD Billion), 2015-2019
20.    Latin America Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2020-2025
21.    Middle East and Africa Generic Injectables Historical Market: Breakup by Country (USD Billion), 2015-2019
22.    Middle East and Africa Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2020-2025
23.    Global Generic Injectables Market Structure

Key Questions Answered in the Report

The global generic injectables market reached a value of USD 32 billion in 2019. 

The market is projected to grow at a CAGR of nearly 9% in the forecast period of 2020-2025.
 

The market is estimated to reach a value of about USD 54 billion by 2025.

The major drivers of the industry include rising disposable incomes, increasing population, rising prevalence of chronic, lethal, and lifestyle diseases, and sudden increase in the overall healthcare costs.

The development of the latest formulations by manufacturers is expected to be a key trend guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.

The oncology segment is the dominant application sector of the product in the market. 

The major containers used in the industry can be divided into vials, ampoules, premix, and prefilled syringes, among others.

The hospitals segment accounts for the largest market share, among other distribution channels in the industry.

The leading players in the market are Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Sanofi, and Sandoz (Novartis), among others.

Analyst Review

The global generic injectables market attained a value of USD 32 billion in 2019, driven by the growth in the overall healthcare costs. Aided by the rising geriatric population and the growing demand for cost-effective treatment procedures, the industry is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 9%. The industry is projected to reach USD 54 billion by 2025. 

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its applications, the global market can be segmented into oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular, among others, with oncology accounting for the largest market share. By containers, the industry can be segmented into vials, ampoules, premix, and prefilled syringes, among others. On the basis of distribution channel, hospitals account for the largest share in the global industry. The major regional markets are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Sanofi, and Sandoz (Novartis), among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1099     $999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 2999     $1999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 3999     $2999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 4999     $3999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Anti-Fibrinolytic Drugs Market Report and Forecast 2020-2025


Global Trenbolone Enanthate Market Report and Forecast 2020-2025


Global Alprazolam Powder Market Report and Forecast 2020-2025


Global Legal Marijuana Market Report and Forecast 2020-2025



NEWSLETTER